| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/30/2004 | CN1155708C DNA of encoding plasminogen excited protein |
| 06/30/2004 | CN1155619C Anti-TPO monoclonal antibody |
| 06/30/2004 | CN1155616C Human protein with cancer cell growth promoting function and its coding sequence |
| 06/30/2004 | CN1155615C Human protein with cancer cell growth suppressing function and its coding sequence |
| 06/30/2004 | CN1155614C Human protein with cancer cell growth suppressing function and its coding sequence |
| 06/30/2004 | CN1155407C Method for preparing intestinal transmitted non-A and non-B hepatitis vaccine |
| 06/29/2004 | US6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain |
| 06/29/2004 | US6756491 Receptor polypeptide for use in the treatment of urogenital disorders and cushing's syndrome |
| 06/29/2004 | US6756483 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756478 Polypeptide for use in diagnosis and treatment of infections |
| 06/29/2004 | US6756213 Nucleic acid encoding retinoic acid receptor |
| 06/29/2004 | US6756211 Neutropohil inhibitors |
| 06/29/2004 | US6756201 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 |
| 06/29/2004 | US6756041 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process |
| 06/29/2004 | CA2294476C Semaphorin receptors |
| 06/29/2004 | CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas) |
| 06/24/2004 | WO2004053163A1 Method for identifying, analyzing and/or cloning nucleic acid isoforms |
| 06/24/2004 | WO2004053139A1 A method of antibody production |
| 06/24/2004 | WO2004053076A2 Methods for rapid detection and identification of bioagents for environmental and product testing |
| 06/24/2004 | WO2004052276A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/24/2004 | WO2004052275A2 Methods of producing lignin peroxidase and its use in skin and hair lightening |
| 06/24/2004 | WO2004033627A3 Methods for efficient production of mammalian recombinant proteins |
| 06/24/2004 | WO2004020653A3 Analytical method for the determination of infant formula protein digestibility in vitro |
| 06/24/2004 | WO2004017899A3 Mono-specific polyclonal antibodies and methods for detecting clostridium difficile toxin a |
| 06/24/2004 | WO2003086311A3 Methods for treating tweak-related conditions |
| 06/24/2004 | WO2003047336A3 TRANSGENIC ANIMALS BEARING HUMAN Igμ LIGHT CHAIN GENES |
| 06/24/2004 | WO2003033666A3 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
| 06/24/2004 | WO2003015613A3 Molecular characteristics of non-small cell lung cancer |
| 06/24/2004 | WO2003008560A8 A novel g protein-coupled receptor, gave8 |
| 06/24/2004 | WO2002092758A9 Gastrokines and derived peptides including inhibitors |
| 06/24/2004 | WO2002086075A3 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs |
| 06/24/2004 | US20040121956 For therapy of diseases in animals and for the control of insects that are injurious or harmful to plants or animals |
| 06/24/2004 | US20040121949 For preparation of food additives or supplements in the medical field, as a source of easily assimilable amino acids useful for trophism of the osteo-articular system, scalp, nails and other particular tissues |
| 06/24/2004 | US20040121465 Optimization of gene sequences of virus-like particles for expression in insect cells |
| 06/24/2004 | US20040121462 Method of screening germ cell-free protein synthesis and method of producing germ extract for cell-free protein synthesis |
| 06/24/2004 | US20040121454 Microreactor |
| 06/24/2004 | US20040121446 Induction of gene expression using a high concentration sugar mixture |
| 06/24/2004 | US20040121445 Cell cultures |
| 06/24/2004 | US20040121443 Modified protamine with reduced immunogenicity |
| 06/24/2004 | US20040121427 Producing calcium preparation via hydrolysis, phosphorylation and calcium-binding reaction with soybean protein; treatment for osteoporosis |
| 06/24/2004 | US20040121387 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/24/2004 | US20040121372 Comprises receptors for advanced glycation endproduct polypeptides for use in diagnosis and treatment inflammation, infection, sepsis, autoimmune, atherosclerotic and nervous system disorders |
| 06/24/2004 | US20040121370 Novel composition and methods for the treatment of immune related diseases |
| 06/24/2004 | US20040121346 Designing and construction of transcription template for synthesizing cell-free protein, and dilution batch-type method of synthesizing cell-free wheat germ protein by using the same |
| 06/24/2004 | US20040121325 Beta 1,2-xylosyltransferase-gene from arabidopsis |
| 06/24/2004 | US20040121314 using primers which hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions that uniquely identify the bioagent, resulting in a base composition signature (BCS) |
| 06/24/2004 | US20040120957 Use of A33 antigens JAM-it |
| 06/24/2004 | US20040120952 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 06/24/2004 | US20040120951 Human-type anti-blood coagulation factor viii antibody |
| 06/24/2004 | US20040120948 antibody or a functional fragment thereof that recognizes a human CD40 antigen present on the surface of human B cells, dendritic cells |
| 06/24/2004 | US20040120945 Cell surface molecule mediating cell adhesion and signal transmission |
| 06/23/2004 | EP1431394A1 Method to produce heterologous glycosylated proteins in bryophyte cells |
| 06/23/2004 | EP1431391A2 Rantes mutants and therapeutic applications thereof |
| 06/23/2004 | EP1431389A2 Cellulase variants |
| 06/23/2004 | EP1431310A1 RECOMBINANT ANTI−OSTEOPONTIN ANTIBODY AND USE THEREOF |
| 06/23/2004 | EP1430152A2 Gene and protein relating to hepatocellular carcinoma |
| 06/23/2004 | EP1430132A2 Methods of using 33751, a human potassium channel family member |
| 06/23/2004 | EP1430131A2 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 06/23/2004 | EP1430130A2 Nucleic acid-associated proteins |
| 06/23/2004 | EP1430129A2 Asip-related proteins |
| 06/23/2004 | EP1430126A1 Dna sequences for human angiogenesis genes |
| 06/23/2004 | EP1430124A2 Artificial ubiquitous chromatin opening elements (ucoe) |
| 06/23/2004 | EP1430082A2 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 06/23/2004 | EP1430079A1 Fluorescent proteins |
| 06/23/2004 | EP1430078A2 Method for increasing the solubility, expression rate and the activity of proteins during recombinant production |
| 06/23/2004 | EP1430070A2 Novel clark protein and nucleic acid molecules and uses therefor |
| 06/23/2004 | EP1429806A2 Extracellular massengers |
| 06/23/2004 | EP1429797A2 Diagnosis and treatment of malignant neoplasms |
| 06/23/2004 | EP1342730A4 Fusion protein having the enhanced in vivo activity of erythropoietin |
| 06/23/2004 | EP1068323B1 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 06/23/2004 | EP0977861B1 Mammalian cytokine-like factor 7 |
| 06/23/2004 | CN1507452A Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 06/23/2004 | CN1506463A Method for yeast cell to express human interleukin 10 |
| 06/23/2004 | CN1154736C Methods and compositions for secretion of heterologous polypeptides |
| 06/23/2004 | CN1154733C Improved heat-stable DNA polymerase |
| 06/23/2004 | CN1154732C Synthetic HPV6/11 hybrid Li DNA encoding human papliomavirus type 11 L1 protein |
| 06/23/2004 | CN1154731C Gene of hop latent virus and methods for detecting the same |
| 06/23/2004 | CN1154730C Compounds and methods for diagnosis of tuberculosis |
| 06/23/2004 | CN1154727C Recombinant expression vector of human parathyroid hormone using phosphoribulokinase as fusion partner |
| 06/23/2004 | CN1154726C OB protein derivatives having prolonged half-life |
| 06/23/2004 | CN1154660C Hybrid molecules between heat-labile enterotoxin and cholera toxic B subunits |
| 06/23/2004 | CN1154659C Novel anti-AIDS immunotoxins |
| 06/23/2004 | CN1154658C Process for the purification of glycoproteins like erythropoietin |
| 06/22/2004 | US6753449 Allyl-5-aminopentanoic acid/2-/ covalently attached to an agarose or polystyrene solid supports; use for building pharmaceutical drugs collections libraries |
| 06/22/2004 | US6753313 Multimeric Apoa-I agonist compounds |
| 06/22/2004 | US6753176 Genetic engineering; antiarthritic agents |
| 06/22/2004 | US6753166 Nucleotide sequences coding polypeptides for use in the treatment of inflammatory and autoimmune diseases |
| 06/22/2004 | US6753165 Methods for making proteins containing free cysteine residues |
| 06/22/2004 | US6752991 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
| 06/22/2004 | CA2210620C Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen |
| 06/22/2004 | CA2176926C .alpha.v.beta.3 integrin as a predictor of endometriosis |
| 06/22/2004 | CA2164672C Process for purifying hepatitis b viral surface antigen comprising pres2 peptide |
| 06/22/2004 | CA2142197C Monoclonal antibody recognizing fk506-binding protein method for assaying fk506-binding protein level, and kit therefor |
| 06/22/2004 | CA2118760C Diagnosis and monitoring of colon cancer patients by measurement of nca 50/90 in blood |
| 06/22/2004 | CA2118759C Diagnosis and monitoring of lung cancer patients by measurement of nca 50/90 in blood |
| 06/17/2004 | WO2004050891A1 Method of producing protein |
| 06/17/2004 | WO2004050868A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof |
| 06/17/2004 | WO2004050864A1 Culture chamber for biologicals |
| 06/17/2004 | WO2004050849A2 Recombinant immunotoxin and use in treating tumors |